1. Home
  2. IMMR vs TARA Comparison

IMMR vs TARA Comparison

Compare IMMR & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

N/A

Current Price

$7.57

Market Cap

215.8M

Sector

Technology

ML Signal

N/A

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

N/A

Current Price

$4.02

Market Cap

236.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMR
TARA
Founded
1993
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.8M
236.1M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
IMMR
TARA
Price
$7.57
$4.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$13.50
$24.40
AVG Volume (30 Days)
513.2K
651.1K
Earning Date
04-13-2026
05-01-2026
Dividend Yield
5.11%
N/A
EPS Growth
N/A
38.25
EPS
0.14
N/A
Revenue
$35,013,000.00
$2,948,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$326.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$2.97
52 Week High
$7.50
$7.82

Technical Indicators

Market Signals
Indicator
IMMR
TARA
Relative Strength Index (RSI) 68.37 45.44
Support Level $6.31 $3.69
Resistance Level N/A $4.23
Average True Range (ATR) 0.29 0.17
MACD 0.04 0.01
Stochastic Oscillator 85.61 23.26

Price Performance

Historical Comparison
IMMR
TARA

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: